Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,230 | 7,495 | 86,230 | 22,669 | 14,414 |
| Marketable Securities | 49,824 | 73,688 | 20,946 | 25,958 | 46,877 |
| Receivables | 3,098 | 2,141 | 528 | 4,715 | 1,926 |
| Inventories | 1,285 | 1,028 | 1,237 | 7,984 | 8,063 |
| Other current assets | 6,630 | 6,710 | 0 | 0 | 0 |
| TOTAL | $77,160 | $95,084 | $115,322 | $67,193 | $77,396 |
| Non-Current Assets | |||||
| PPE Net | 5,936 | 5,843 | 6,163 | 6,205 | 6,384 |
| Intangibles | 5,873 | 6,080 | 6,287 | 13,493 | 14,013 |
| Other Non-Current Assets | 11,243 | 10,000 | 3,250 | 0 | 0 |
| TOTAL | $23,052 | $21,923 | $15,700 | $19,698 | $20,397 |
| Total Assets | $100,212 | $117,007 | $131,022 | $86,891 | $97,793 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,333 | 3,333 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,263 | 7,350 | 7,512 | 5,349 | 8,766 |
| Accrued Expenses | 2,146 | 4,626 | 3,815 | 2,944 | 2,505 |
| Other current liabilities | 2,531 | 3,201 | 3,543 | 2,146 | 2,310 |
| TOTAL | $17,273 | $18,510 | $14,870 | $11,883 | $14,459 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,975 | 15,728 | 17,484 | 18,745 | 18,435 |
| Deferred Revenues | N/A | N/A | 0 | 1,444 | 878 |
| Other Non-Current Liabilities | 600 | 734 | 8,358 | 2,047 | 611 |
| TOTAL | $14,575 | $16,462 | $25,842 | $23,588 | $21,848 |
| Total Liabilities | $31,848 | $34,972 | $40,712 | $35,471 | $36,307 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,586 | 21,113 | 21,428 | 21,419 | 21,200 |
| Common Shares | 22 | 22 | 21 | 21 | 21 |
| Retained earnings | -87,573 | -73,719 | -63,958 | -101,826 | -90,637 |
| Other shareholders' equity | -83 | -105 | -10 | -14 | -41 |
| TOTAL | $68,364 | $82,035 | $90,310 | $51,420 | $61,486 |
| Total Liabilities And Equity | $100,212 | $117,007 | $131,022 | $86,891 | $97,793 |